期刊文献+

HPLC法测定胸腺五肽及其有关杂质 被引量:3

Determination of thymopentin and its related impurities
下载PDF
导出
摘要 目的:建立具有普适性的高效液相色谱法测定胸腺五肽及相关杂质。方法:采用 Kromasil-C_(18)柱(4.6 mm×250 mm,5 μm),流动相为40 mmol·L^(-1)磷酸二氢钠缓冲液(pH 3.75)-甲醇(85:15),流速:1 mL·min^(-1),检测波长:210 nm。结果:线性范围为1.66~212.4 μg·mL^(-1),r=0.9998,最低检测限量为10 ng,本方法重复性和精密度良好(RSD<2%)。结论:采用HPLC 法可测定不同合成工艺合成的胸腺五肽粗肽、成品及其有关杂质,方法简便,结果准确。 Objective:To establish HPLC method for determination of thymopentin (TP -5) and its related impurities. Methods:Kromasil - C18 column(4.6 mm ×250 mm,5 μm) was used; The mobile phase was 40 mmol· L^-1 Nail2 PO4 ( pH 3.75 ) - methanol (85: 15 ) at a flow rate of 1.0 mL·min^-1. TP - 5 was eluted with the same solvent. The detection wavelength was 210 nm. Results:There was a good relationship with the range of 1.66 -212. 4μg· mL^-1( r = 0. 9998 ). The repeatability and precision of the method were good (RSD 〈 2% ). Conclusion:The method to determine the content and the related impurities of TP -5 by HPLC is simple and accurate.
出处 《药物分析杂志》 CAS CSCD 北大核心 2007年第5期764-766,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 胸腺五肽 高效液相色谱法 相关杂质 thymopentin HPLC related impurities
  • 相关文献

参考文献4

二级参考文献9

共引文献36

同被引文献17

  • 1乞国艳.胸腺五肽对恶性肿瘤化疗前后T淋巴细胞AgNORs的影响[J].河北医药,2004,26(12):960-960. 被引量:3
  • 2贺晓慧,贾孟辉,俞维,田建英.宁夏枸杞叶基础研究述要及应用开发的前景[J].时珍国医国药,2007,18(5):1111-1112. 被引量:31
  • 3汤南,张丹,孙文霞.RP-HPLC法测定注射用胸腺五肽中主药及有关物质的含量[J].中国药房,2007,18(16):1252-1253. 被引量:3
  • 4GOLDSTEIN G,SCHEID MP,BOYSE EA,et al.Synthetic pentapeptide with biological-activity characteristic of the thymic hormone thympoietin[J].Scieoce,1979,204(4399):1309-1310.
  • 5CASCINELLI N,CLEMENTE C,BUFALINO R,et al.Perinodular injection of thymopentin (TP-5)in cutaneous and subcutaneous metastases of melanoma[J].Melanoma Res,1993,3(6):471.
  • 6Drug Specifications Promulgated by the Ministry of Public Health,P R China (中华人民共和国卫生部部颁标准).WS290(X-248)-96.Quality Standard of Thymopentin(胸腺五肤质量标准)[S].
  • 7VOLKER J H,BERND W M.Stabifity of the synthetic Pentapepdde thyrnopentin in aqueous solution:Effect of pH and buffer on the degaration[J].Int J Pbarrn,1991,70(1):29-94.
  • 8国家药品标准.注射用胸腺五肽质量标准(WS1-(X-013)-2004Z).
  • 9国家药品标准.胸腺五肽质量标准(WS1-(X-027)-2004Z).
  • 10Stephens J M, Botteman M F,Hay J W. Economic Impact of Antidiabetic Medications and Glycemic Control on Managed Care Organizations: A Review of the Literature[J]. Journal of Managed Care Pharmacy, 2006,12(2):130--142.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部